Cipla gets DCGI nod to sell Favipiravir under brand ‘Ciplenza’
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand …
Cipla gets DCGI nod to sell Favipiravir under brand ‘Ciplenza’ Read More